Plain-English translation of NCT07174505 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new device called the CONDA stent retriever, which is designed to remove blood clots from blood vessels in the brain during an acute ischemic stroke. Doctors use this device in a procedure called mechanical thrombectomy to physically pull out the clot and restore blood flow to the brain. The study wants to make sure this new device is safe and works as well as other clot-removal devices already in use.
When someone has a stroke caused by a blood clot blocking a large vessel in the brain, quick removal of that clot can prevent serious brain damage. This trial is testing whether the CONDA device can safely and effectively remove these clots as part of standard stroke care.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will receive mechanical thrombectomy using the CONDA device as part of your emergency stroke care—this is not an experimental procedure, but rather a new version of a standard treatment. Your doctors will perform imaging scans to confirm the clot location and monitor your progress. You will need to return for a follow-up visit 90 days after your stroke so researchers can assess how well you recovered.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
Hungary
Spain